Literature DB >> 791322

The effect of chloramphenicol and sulphaphenazole on the biotransformation of cyclophosphamide in man.

O K Faber, H T Mouridsen, L Skovsted.   

Abstract

1 The metabolism of cyclophosphamide was investigated before and following treatment with chloramphenicol (five subject) and sulphaphenazole (seven subjects). 2 The biotransformation of cyclophosphamide was retarded after chloramphenicol treatment as indicated by prolongation in the mean serum half-life from 7.5 h to 11.5 h combined with decreased peak activity and integrated concentrations of metabolites. 3 In the sulphaphenazole treated subjects the rate of biotransformation of cyclophosphamide was significantly inhibited in two, unaltered in three and enhanced in two. The inconsistency of the results is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 791322      PMCID: PMC1402585          DOI: 10.1111/j.1365-2125.1975.tb01589.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  [ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO].

Authors:  N BROCK; H J HOHORST
Journal:  Arzneimittelforschung       Date:  1963-12

2.  SULPHAPHENAZOLE-INDUCED HYPOGLYCAEMIC ATTACKS IN TOLBUTAMIDE-TREATED DIABETICS.

Authors:  L K CHRISTENSEN; J M HANSEN; M KRISTENSEN
Journal:  Lancet       Date:  1963-12-21       Impact factor: 79.321

3.  Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat.

Authors:  J L Cohen; J Y Jao
Journal:  J Pharmacol Exp Ther       Date:  1970-08       Impact factor: 4.030

4.  Inhibition of drug metabolism by chloramphenicol.

Authors:  L K Christensen; L Skovsted
Journal:  Lancet       Date:  1969-12-27       Impact factor: 79.321

5.  The biotransformation of cyclophosphamide in man: analysis of the variation in normal subjects.

Authors:  H T Mouridsen; O Faber; L Skovsted
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-08

6.  Metabolism of cyclophosphamide-C14 by various marine species.

Authors:  L B Mellett; S M el-Dareer; D P Rall; R H Adamson
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-01

7.  Effect of chloramphenicol on the metabolism and lethality of cyclophosphamide in rats.

Authors:  R L Dixon
Journal:  Proc Soc Exp Biol Med       Date:  1968-04

8.  [Alkylating substances in serum and urine after injection of cyclophosphamide].

Authors:  H J Hohorst; A Ziemann; N Brock
Journal:  Arzneimittelforschung       Date:  1965-04
  8 in total
  3 in total

Review 1.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

Review 2.  Drug interactions and clinical pharmacokinetics.

Authors:  M B Kristensen
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of cyclophosphamide.

Authors:  Milly E de Jonge; Alwin D R Huitema; Sjoerd Rodenhuis; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.